home  Home
What is depression
Depression Q&A's
Help in your area
What's on in your area
Family and Friends
Treatments
People
Inspiration
Articles
Your contributions
Your stories
Books
In the news
Research
About Us
Feedback
Links
MESSAGE BOARD
CHAT ROOM
  contact us
In The News

Discontinuation Of Serzone (nefazodone) in Australia
20th January 2004
MEDIA RELEASE


Bristol-Myers Squibb Australia Pty Ltd is discontinuing sales of the antidepressant Serzone® (nefazodone) in Australia, effective 30 April 2004, because of its current low and declining rate of use.

The company is notifying health care professionals of this decision to allow adequate time to switch those patients who are currently taking Serzone to another antidepressant and initiate new patients on alternative therapies.

Bristol-Myers Squibb is advising prescribers to consult the full prescribing information for Serzone prior to ceasing treatment with Serzone and switching patients to alternative therapy. It is also recommending that prescribers consult the Product Information for any product that they may consider as an alternative treatment.

Prescribers can obtain more information from the Bristol-Myers Squibb Medical Information Department on 1800 067 567.

Media enquiries:
Michael Moore
(03) 9213 4349 or 0407 759253

©Mensline Australia. Reproduced with Permission

Your feedback and input will be greatly appreciated.

If you have a service or product that may be of assistance to people with depression or a related condition, or their support people, please contact us for details on how to be listed or contribute to this site.

Keeping Safe | Contact us | Site map | Privacy | Disclaimer
Copyright © 2005 depressioNet